Theresa Franco, Marc Stewart, Douglas Wood, and Donna Powell receive NCCN’s 2023 awards

NCCN adds Lymphir to Clinical Practice Guidelines in Oncology

The National Comprehensive Cancer Network added Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma after at least one prior systemic therapy, to the NCCN Clinical Practice Guidelines in Oncology. Lymphir is included based on an NCCN Category 2A recommendation which indicates a uniform NCCN consensus that the drug is appropriate as an option for patients with CTCL.

September 06, 2024

Vol.50 No.33

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.

Fred Hutch announces eight recipients of 2024 Eddie Méndez Scholar Award

Fred Hutch Cancer Center announced the recipients of the 2024 Dr. Eddie Méndez Scholar Award, which recognizes early-career scientists from underrepresented backgrounds who are studying cancer, infectious diseases, and basic sciences.

June 21, 2024

Vol.50 No.25

In Brief

NCCN patient resources receive Hemes Creative Award, Communicator Award, Viddy Award

The National Comprehensive Cancer Network announced recognitions for the award-winning library of NCCN Guidelines for Patients and NCCN Patient Webinars.

June 21, 2024

Vol.50 No.25

Editorial

The Cancer Letter receives six journalism, design awards

The Cancer Letter staff were finalists for six 2024 Dateline Awards from the Washington, DC, Chapter of the Society of Professional Journalists—three for journalism, and three for design—and won first place for two.

Dennis Slamon receives Szent-Györgyi Prize from National Foundation for Cancer Research

Dennis Slamon, an oncologist and scientist whose research has transformed the treatment of breast cancer, was awarded the 2024 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.

June 07, 2024

Vol.50 No.23

Theresa Franco, Marc Stewart, Douglas Wood, and Donna Powell receive NCCN’s 2023 awards

YOU MAY BE INTERESTED IN

NCCN adds Lymphir to Clinical Practice Guidelines in Oncology

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

Fred Hutch announces eight recipients of 2024 Eddie Méndez Scholar Award

NCCN patient resources receive Hemes Creative Award, Communicator Award, Viddy Award

The Cancer Letter receives six journalism, design awards

Dennis Slamon receives Szent-Györgyi Prize from National Foundation for Cancer Research

Renew today!

Subscriber content

Login

Theresa Franco, Marc Stewart, Douglas Wood, and Donna Powell receive NCCN’s 2023 awards

YOU MAY BE INTERESTED IN

NCCN adds Lymphir to Clinical Practice Guidelines in Oncology

Platinum drugs are off the shortage list, but the underlying problem is unsolvedFDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

Fred Hutch announces eight recipients of 2024 Eddie Méndez Scholar Award

NCCN patient resources receive Hemes Creative Award, Communicator Award, Viddy Award

The Cancer Letter receives six journalism, design awards

Dennis Slamon receives Szent-Györgyi Prize from National Foundation for Cancer Research

Login

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”